Facilitated By

San Antonio Medical Foundation

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Of Oral Ozanimod As Maintenance Therapy For Moderately To Severely Active Crohn's Disease

Brooke Army Medical Center

Brooke Army Medical Center (BAMC) at Fort Sam Houston, Texas, is proud to provide safe, quality care to our military service members, their families, veterans and civilian emergency patients as the most robust and productive healthcare organization within the Military Health System (MHS).

Funded by
Research Start Date

Whereas, the Federal Laboratory and the Collaborating Party are entering into this Agreement for the mutual benefit of each Party.  This joint research project will benefit the Collaborating Party by accomplishing its mission to promote and support the advancement of military medicine and specifically military medical research.  The project will benefit the Federal Laboratory by providing valuable research experience for the medical residents of the teaching program involved.  In addition, patients at SAMMC with moderately to severely active Crohn's Disease may benefit through potential use of oral Ozanimod.

Collaborative Project
Clinical Care
Infectious Disease
The appearance of name-brand products in this article does not constitute endorsement by Brooke Army Medical Center, the U.S. Army Medical Center, the U.S. Army Medical Department, the U.S. Army Office of the Surgeon General, the Department of the Army, the Department of Defense, or the U.S. Government of the information, products, or services contained therein.